Free Trial

Calix (CALX) Financials

Calix logo
$33.44 -1.38 (-3.97%)
Closing price 03:59 PM Eastern
Extended Trading
$33.34 -0.09 (-0.28%)
As of 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Calix

Annual Income Statements for Calix

This table shows Calix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-26 -27 -83 -19 -18 33 238 41 29 -30
Consolidated Net Income / (Loss)
-26 -27 -83 -19 -18 33 238 41 29 -30
Net Income / (Loss) Continuing Operations
-26 -27 -83 -19 -18 33 238 41 29 -30
Total Pre-Tax Income
-26 -27 -82 -19 -17 34 73 54 35 -32
Total Operating Income
-27 -28 -82 -19 -15 37 74 53 26 -43
Total Gross Profit
190 201 173 197 188 267 357 435 518 454
Total Revenue
407 459 510 441 424 541 679 868 1,040 832
Operating Revenue
407 459 510 441 424 541 679 868 1,040 832
Total Cost of Revenue
217 258 337 244 236 274 323 432 521 378
Operating Cost of Revenue
217 258 337 244 236 274 323 432 521 378
Total Operating Expenses
217 229 254 216 203 230 283 383 493 497
Selling, General & Admin Expense
38 42 40 41 37 44 56 76 100 99
Marketing Expense
79 84 83 86 83 94 126 175 215 218
Research & Development Expense
90 107 128 90 81 85 102 132 178 180
Total Other Income / (Expense), net
0.71 1.06 -0.23 -0.25 -1.13 -2.56 -1.28 1.43 9.17 11
Interest & Investment Income
0.14 0.15 -0.16 -0.63 -0.96 -1.59 -0.40 2.01 9.70 12
Other Income / (Expense), net
0.57 0.91 -0.07 0.38 -0.17 -0.98 -0.88 -0.58 -0.53 -0.96
Income Tax Expense
0.54 0.35 1.24 0.53 1.16 0.80 -166 13 5.43 -1.90
Basic Earnings per Share
($0.51) ($0.56) ($1.66) ($0.37) ($0.32) $0.57 $3.77 $0.63 $0.44 ($0.45)
Weighted Average Basic Shares Outstanding
51.49M 48.73M 50.16M 52.61M 54.99M 59.07M 63.28M 65.06M 65.98M 65.88M
Diluted Earnings per Share
($0.51) ($0.56) ($1.66) ($0.37) ($0.32) $0.54 $3.51 $0.60 $0.42 ($0.45)
Weighted Average Diluted Shares Outstanding
51.49M 48.73M 50.16M 52.61M 54.99M 62.00M 67.86M 68.91M 69.32M 65.88M
Weighted Average Basic & Diluted Shares Outstanding
51.49M 48.73M 50.16M 52.61M 54.99M 62.45M 64.44M 66.14M 65.41M 66.69M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 - $0.00 $0.00

Quarterly Income Statements for Calix

This table shows Calix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
13 12 9.60 9.37 17 -6.60 0.10 -7.96 -3.97 -18
Consolidated Net Income / (Loss)
13 12 9.60 9.37 17 -6.60 0.10 -7.96 -3.97 -18
Net Income / (Loss) Continuing Operations
13 12 9.60 9.37 17 -6.60 0.10 -7.96 -3.97 -18
Total Pre-Tax Income
20 14 11 14 18 -9.02 0.47 -8.68 -7.79 -16
Total Operating Income
20 13 9.94 12 16 -12 -2.03 -11 -11 -19
Total Gross Profit
119 125 128 136 141 113 123 108 110 113
Total Revenue
236 245 250 261 264 265 226 198 201 206
Operating Revenue
236 245 250 261 264 265 226 198 201 206
Total Cost of Revenue
118 120 122 125 123 151 104 91 91 93
Operating Cost of Revenue
118 120 122 125 123 151 104 91 91 93
Total Operating Expenses
99 112 118 125 125 125 125 119 121 132
Selling, General & Admin Expense
19 22 23 25 25 27 26 23 23 27
Marketing Expense
46 51 52 55 52 56 54 52 52 59
Research & Development Expense
33 39 43 45 47 42 44 44 45 46
Total Other Income / (Expense), net
0.46 0.97 1.47 2.42 2.21 3.07 2.50 2.67 3.10 3.11
Interest & Investment Income
0.60 1.14 1.64 2.26 2.66 3.15 2.64 2.96 3.28 3.47
Other Income / (Expense), net
-0.13 - -0.17 0.16 -0.44 -0.08 -0.14 -0.29 -0.18 -0.36
Income Tax Expense
7.02 2.16 1.81 4.86 1.19 -2.43 0.37 -0.72 -3.82 2.28
Basic Earnings per Share
$0.21 $0.17 $0.15 $0.14 $0.26 ($0.11) $0.00 ($0.12) ($0.06) ($0.27)
Weighted Average Basic Shares Outstanding
65.36M 65.06M 66.04M 66.27M 66.29M 65.98M 65.34M 65.68M 66.08M 65.88M
Diluted Earnings per Share
$0.19 $0.18 $0.14 $0.13 $0.24 ($0.09) $0.00 ($0.12) ($0.06) ($0.27)
Weighted Average Diluted Shares Outstanding
69.17M 68.91M 69.71M 69.66M 69.58M 69.32M 68.12M 65.68M 66.08M 65.88M
Weighted Average Basic & Diluted Shares Outstanding
65.44M 66.14M 66.24M 66.32M 65.87M 65.41M 65.53M 65.80M 66.32M 66.69M

Annual Cash Flow Statements for Calix

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-25 27 -11 10 -2.82 33 -29 28 -16 -20
Net Cash From Operating Activities
-5.34 24 -63 3.56 4.65 51 57 27 56 68
Net Cash From Continuing Operating Activities
-5.34 24 -63 3.56 4.65 51 57 27 56 68
Net Income / (Loss) Continuing Operations
-26 -27 -83 -19 -18 33 238 41 29 -30
Consolidated Net Income / (Loss)
-26 -27 -83 -19 -18 33 238 41 29 -30
Depreciation Expense
10 8.32 11 9.19 10 14 15 14 17 20
Amortization Expense
19 6.19 - - - 0.00 0.00 -1.15 -4.20 -5.29
Non-Cash Adjustments To Reconcile Net Income
14 14 13 11 14 18 24 45 63 71
Changes in Operating Assets and Liabilities, net
-23 23 -3.38 2.58 -1.79 -14 -221 -72 -48 13
Net Cash From Investing Activities
4.67 12 20 -0.08 -13 -61 -111 -24 -6.25 -110
Net Cash From Continuing Investing Activities
4.67 12 20 -0.08 -13 -61 -111 -24 -6.25 -110
Purchase of Property, Plant & Equipment
-7.28 -9.84 -8.03 -10 -13 -7.82 -10 -14 -18 -18
Purchase of Investments
-60 -16 -8.73 0.00 0.00 -73 -298 -191 -216 -302
Sale and/or Maturity of Investments
72 38 36 0.00 0.00 20 198 181 228 210
Net Cash From Financing Activities
-24 -9.24 32 7.49 5.97 42 24 25 -66 21
Net Cash From Continuing Financing Activities
-24 -9.24 32 7.49 5.97 42 24 25 -66 21
Repurchase of Common Equity
-27 -13 - - - - 0.00 0.00 -86 -11
Other Financing Activities, net
-1.71 -2.08 -2.70 0.31 5.97 12 24 25 20 32
Other Net Changes in Cash
- - - -0.48 - - - - - -0.01
Cash Interest Paid
0.13 0.13 0.31 0.65 1.12 1.69 0.63 0.58 0.25 0.00
Cash Income Taxes Paid
0.48 0.97 0.92 0.56 0.40 0.75 5.20 9.61 12 5.88

Quarterly Cash Flow Statements for Calix

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
24 3.90 15 -4.00 45 -72 25 -3.93 -22 -19
Net Cash From Operating Activities
6.71 6.11 8.11 17 16 15 15 22 16 15
Net Cash From Continuing Operating Activities
6.71 6.11 8.11 17 16 15 15 22 16 15
Net Income / (Loss) Continuing Operations
13 12 9.60 9.37 17 -6.60 0.10 -7.96 -3.97 -18
Consolidated Net Income / (Loss)
13 12 9.60 9.37 17 -6.60 0.10 -7.96 -3.97 -18
Depreciation Expense
3.17 3.48 3.72 4.19 4.27 4.45 4.87 5.12 4.82 4.75
Amortization Expense
-0.53 -0.61 -0.71 -1.19 -1.22 -1.08 -1.41 -1.31 -1.24 -1.33
Non-Cash Adjustments To Reconcile Net Income
11 13 16 18 16 13 17 15 16 22
Changes in Operating Assets and Liabilities, net
-20 -22 -21 -13 -20 5.47 -5.73 11 0.02 7.80
Net Cash From Investing Activities
10 -6.87 -3.28 -15 57 -45 3.28 -30 -49 -34
Net Cash From Continuing Investing Activities
10 -6.87 -3.28 -15 57 -45 3.28 -30 -49 -34
Purchase of Property, Plant & Equipment
-3.39 -4.81 -4.62 -5.49 -3.78 -3.97 -3.71 -5.95 -3.24 -5.15
Purchase of Investments
-39 -49 -55 -51 -28 -83 -36 -113 -80 -73
Sale and/or Maturity of Investments
53 47 56 41 89 42 43 89 34 45
Net Cash From Financing Activities
6.61 4.56 10 -6.03 -28 -43 7.08 4.02 11 -0.80
Net Cash From Continuing Financing Activities
6.61 4.56 10 -6.03 -28 -43 7.08 4.02 11 -0.80
Repurchase of Common Equity
- - -1.18 -8.82 -32 -44 -3.74 - - -6.96
Other Financing Activities, net
6.61 4.56 11 2.79 4.90 1.37 11 4.02 11 6.16

Annual Balance Sheets for Calix

This table presents Calix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
324 355 295 317 317 427 742 885 942 939
Total Current Assets
183 219 162 175 144 267 409 547 598 585
Cash & Equivalents
24 50 40 50 47 81 51 79 63 43
Short-Term Investments
50 28 - - 0.00 53 153 163 157 254
Accounts Receivable
47 51 80 67 47 69 85 94 126 79
Inventories, net
48 45 32 50 40 52 89 149 133 103
Prepaid Expenses
9.47 11 11 7.31 9.70 11 31 63 119 106
Plant, Property, & Equipment, net
17 18 16 25 22 20 22 26 29 31
Total Noncurrent Assets
124 118 117 117 151 140 311 312 314 323
Goodwill
116 116 116 116 116 116 116 116 116 116
Noncurrent Deferred & Refundable Income Taxes
- - - - - 0.00 169 167 168 178
Other Noncurrent Operating Assets
1.14 1.99 0.76 1.20 35 24 26 28 31 30
Total Liabilities & Shareholders' Equity
324 355 295 317 317 427 742 885 942 939
Total Liabilities
88 143 150 165 163 147 174 205 223 158
Total Current Liabilities
67 121 128 144 115 101 128 165 188 131
Accounts Payable
20 24 36 40 11 13 29 41 35 20
Accrued Expenses
36 70 49 58 58 69 72 90 116 84
Current Deferred Revenue
12 28 13 16 17 19 27 34 37 27
Total Noncurrent Liabilities
21 21 22 21 47 46 45 40 35 27
Noncurrent Deferred Revenue
20 20 21 17 18 20 22 25 25 21
Other Noncurrent Operating Liabilities
1.29 0.88 1.13 3.97 29 26 23 15 10 6.30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
236 213 145 152 154 280 568 680 719 781
Total Preferred & Common Equity
236 213 145 152 154 280 568 680 719 781
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
236 213 145 152 154 280 568 680 719 781
Common Stock
820 838 852 878 897 950 999 1,072 1,080 1,172
Retained Earnings
-557 -584 -667 -685 -703 -669 -431 -390 -360 -390
Accumulated Other Comprehensive Income / (Loss)
-0.20 -0.66 -0.17 -0.75 -0.85 -0.19 -0.32 -2.47 -0.66 -0.61

Quarterly Balance Sheets for Calix

This table presents Calix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
867 915 942 927 923 918 938
Total Current Assets
535 576 599 588 579 570 585
Cash & Equivalents
75 94 90 136 88 84 62
Short-Term Investments
160 163 174 114 151 177 225
Accounts Receivable
101 92 97 81 100 82 85
Inventories, net
141 157 153 150 120 113 101
Prepaid Expenses
59 70 85 107 119 113 112
Plant, Property, & Equipment, net
24 27 29 29 29 31 31
Total Noncurrent Assets
307 311 314 310 315 317 321
Goodwill
116 116 116 116 116 116 116
Noncurrent Deferred & Refundable Income Taxes
164 168 166 163 170 173 178
Other Noncurrent Operating Assets
27 27 31 31 29 27 27
Total Liabilities & Shareholders' Equity
867 915 942 927 923 918 938
Total Liabilities
219 197 200 176 180 164 159
Total Current Liabilities
181 161 162 139 146 133 130
Accounts Payable
66 35 35 22 19 12 24
Accrued Expenses
81 81 85 82 88 89 76
Current Deferred Revenue
34 44 42 35 39 32 30
Total Noncurrent Liabilities
39 36 38 37 34 31 29
Noncurrent Deferred Revenue
25 25 25 25 24 22 21
Other Noncurrent Operating Liabilities
14 11 12 11 9.58 8.60 7.55
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
648 718 742 751 743 754 779
Total Preferred & Common Equity
648 718 742 751 743 754 779
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
648 718 742 751 743 754 779
Common Stock
1,052 1,099 1,114 1,106 1,104 1,123 1,150
Retained Earnings
-402 -380 -371 -354 -360 -368 -372
Accumulated Other Comprehensive Income / (Loss)
-3.08 -1.31 -1.59 -1.36 -0.98 -0.97 0.49

Annual Metrics and Ratios for Calix

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
1.55% 12.60% 11.24% -13.53% -3.85% 27.55% 25.53% 27.74% 19.79% -20.02%
EBITDA Growth
-54.00% -435.03% -456.16% 87.33% 41.24% 1,043.08% 77.60% -25.96% -42.51% -179.30%
EBIT Growth
-28.69% -4.89% -200.03% 77.78% 14.13% 330.31% 103.67% -28.78% -51.85% -275.58%
NOPAT Growth
-30.05% -6.07% -190.04% 77.30% 16.81% 433.80% 574.12% -83.54% -45.93% -239.55%
Net Income Growth
-26.52% -4.06% -203.01% 76.76% 8.31% 289.24% 611.92% -82.80% -28.49% -201.44%
EPS Growth
-24.39% -9.80% -196.43% 77.71% 13.51% 268.75% 550.00% -82.91% -30.00% -207.14%
Operating Cash Flow Growth
-114.03% 557.20% -357.06% 105.67% 30.73% 1,004.62% 10.47% -52.14% 106.93% 21.60%
Free Cash Flow Firm Growth
-225.88% 138.02% -850.13% 83.57% -66.37% 265.83% -3.79% -235.16% -15.85% 60.87%
Invested Capital Growth
0.98% -16.86% 0.25% -2.61% 3.73% 7.30% 148.47% 20.26% 13.88% -2.97%
Revenue Q/Q Growth
-1.60% 6.20% 1.21% -4.83% 1.11% 10.14% 0.95% 8.51% 1.98% -6.58%
EBITDA Q/Q Growth
-63.62% -109.90% -1.92% 39.88% 58.29% 92.74% -10.64% -4.31% -40.17% -30.14%
EBIT Q/Q Growth
-34.76% -8.28% -1.22% 28.42% 29.56% 186.79% -12.82% -3.95% -50.61% -18.70%
NOPAT Q/Q Growth
-35.06% -9.76% -0.65% 29.12% 30.15% 190.19% -1.13% -19.12% -48.54% -18.31%
Net Income Q/Q Growth
-33.16% -7.61% -1.69% 27.41% 25.56% 238.94% -1.74% -16.24% -38.72% -61.48%
EPS Q/Q Growth
-37.84% -7.69% -1.84% 28.85% 27.27% 285.71% -3.31% -15.49% -39.13% -66.67%
Operating Cash Flow Q/Q Growth
-123.91% 2,097.93% -563.13% 112.31% 96.04% 138.49% -23.92% -19.33% 18.59% 0.65%
Free Cash Flow Firm Q/Q Growth
-603.32% 161.57% -529.98% 68.27% 41.14% 1,553.10% -39.73% -101.90% 14.54% 2.40%
Invested Capital Q/Q Growth
-0.31% -14.22% 23.35% 8.77% 3.26% 2.41% 4.95% 6.01% -0.44% -1.48%
Profitability Metrics
- - - - - - - - - -
Gross Margin
46.74% 43.86% 33.88% 44.73% 44.29% 49.33% 52.49% 50.17% 49.86% 54.55%
EBITDA Margin
0.93% -2.77% -13.84% -2.03% -1.24% 9.16% 12.96% 7.51% 3.61% -3.57%
Operating Margin
-6.51% -6.13% -15.98% -4.20% -3.63% 6.81% 10.88% 6.06% 2.46% -5.18%
EBIT Margin
-6.37% -5.93% -15.99% -4.11% -3.67% 6.63% 10.75% 6.00% 2.41% -5.29%
Profit (Net Income) Margin
-6.46% -5.97% -16.27% -4.37% -4.17% 6.19% 35.09% 4.73% 2.82% -3.58%
Tax Burden Percent
102.07% 101.28% 101.52% 102.82% 107.03% 97.67% 328.10% 75.89% 84.37% 94.00%
Interest Burden Percent
99.46% 99.44% 100.20% 103.48% 106.15% 95.58% 99.45% 103.86% 138.73% 71.94%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 2.33% -228.10% 24.11% 15.63% 0.00%
Return on Invested Capital (ROIC)
-11.50% -13.25% -42.28% -9.71% -8.04% 25.42% 95.02% 9.96% 4.61% -6.13%
ROIC Less NNEP Spread (ROIC-NNEP)
-3.12% -3.08% 16.76% 32.47% 28.61% 28.73% 97.51% 9.47% 1.26% -6.28%
Return on Net Nonoperating Assets (RNNOA)
1.14% 1.04% -4.11% -3.29% -3.53% -10.00% -38.85% -3.38% -0.42% 2.17%
Return on Equity (ROE)
-10.36% -12.21% -46.40% -13.00% -11.57% 15.42% 56.17% 6.57% 4.19% -3.97%
Cash Return on Invested Capital (CROIC)
-12.47% 5.15% -42.53% -7.07% -11.70% 18.38% 9.81% -8.44% -8.37% -3.12%
Operating Return on Assets (OROA)
-7.47% -8.01% -25.10% -5.93% -4.91% 9.64% 12.49% 6.40% 2.74% -4.68%
Return on Assets (ROA)
-7.59% -8.07% -25.53% -6.31% -5.58% 9.00% 40.77% 5.04% 3.21% -3.16%
Return on Common Equity (ROCE)
-10.36% -12.21% -46.40% -13.00% -11.57% 15.42% 56.17% 6.57% 4.19% -3.97%
Return on Equity Simple (ROE_SIMPLE)
-11.17% -12.87% -57.28% -12.70% -11.49% 11.94% 41.94% 6.03% 4.08% -3.81%
Net Operating Profit after Tax (NOPAT)
-19 -20 -57 -13 -11 36 243 40 22 -30
NOPAT Margin
-4.55% -4.29% -11.19% -2.94% -2.54% 6.65% 35.71% 4.60% 2.08% -3.62%
Net Nonoperating Expense Percent (NNEP)
-8.38% -10.18% -59.04% -42.19% -36.65% -3.31% -2.49% 0.49% 3.35% 0.15%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 5.87% 3.00% -3.86%
Cost of Revenue to Revenue
53.26% 56.14% 66.12% 55.27% 55.71% 50.67% 47.51% 49.83% 50.14% 45.45%
SG&A Expenses to Revenue
9.44% 9.07% 7.81% 9.18% 8.75% 8.21% 8.21% 8.79% 9.66% 11.89%
R&D to Revenue
22.02% 23.29% 24.99% 20.39% 19.13% 15.75% 14.98% 15.21% 17.10% 21.63%
Operating Expenses to Revenue
53.24% 49.99% 49.86% 48.92% 47.92% 42.53% 41.60% 44.11% 47.40% 59.73%
Earnings before Interest and Taxes (EBIT)
-26 -27 -82 -18 -16 36 73 52 25 -44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3.79 -13 -71 -8.95 -5.26 50 88 65 37 -30
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.70 1.76 2.07 3.41 2.88 6.56 8.97 6.59 4.00 2.96
Price to Tangible Book Value (P/TBV)
3.54 3.88 10.42 14.49 11.73 11.20 11.27 7.95 4.77 3.48
Price to Revenue (P/Rev)
0.98 0.82 0.59 1.17 1.05 3.40 7.50 5.16 2.77 2.78
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 54.90 21.39 109.20 98.13 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 1.82% 4.68% 0.92% 1.02% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.01 2.21 2.15 3.78 3.12 11.63 13.44 9.68 5.33 4.17
Enterprise Value to Revenue (EV/Rev)
0.80 0.65 0.57 1.13 1.01 3.15 7.20 4.88 2.56 2.42
Enterprise Value to EBITDA (EV/EBITDA)
86.07 0.00 0.00 0.00 0.00 34.38 55.57 64.97 70.89 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 47.52 66.99 81.42 106.07 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 47.37 20.17 106.11 123.10 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 12.19 0.00 139.82 91.63 33.16 86.18 155.85 47.24 29.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 38.87 0.00 0.00 0.00 65.51 195.51 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.21 0.20 0.19 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.37 -0.34 -0.25 -0.10 -0.12 -0.35 -0.40 -0.36 -0.33 -0.35
Leverage Ratio
1.37 1.51 1.82 2.06 2.07 1.71 1.38 1.30 1.31 1.25
Compound Leverage Factor
1.36 1.51 1.82 2.13 2.20 1.64 1.37 1.35 1.81 0.90
Debt to Total Capital
0.00% 0.00% 17.15% 16.49% 16.30% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 17.15% 16.49% 16.30% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 82.85% 83.51% 83.70% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 -0.42 -3.35 -5.71 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.14 2.27 3.32 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 -0.53 -2.31 -2.78 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.17 1.56 1.62 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
1.74 0.65 -1.01 0.18 -0.18 7.32 18.50 14.17 8.93 9.49
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.72 1.81 1.27 1.22 1.25 2.64 3.19 3.31 3.19 4.46
Quick Ratio
1.80 1.07 0.94 0.81 0.81 2.01 2.26 2.03 1.85 2.87
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-20 7.65 -57 -9.43 -16 26 25 -34 -39 -15
Operating Cash Flow to CapEx
-73.39% 248.19% -782.11% 34.15% 34.85% 657.49% 542.80% 193.24% 315.04% 378.86%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.17 1.35 1.57 1.44 1.34 1.45 1.16 1.07 1.14 0.88
Accounts Receivable Turnover
10.46 9.32 7.75 5.99 7.47 9.34 8.79 9.70 9.46 8.10
Inventory Turnover
4.60 5.59 8.87 5.97 5.24 5.93 4.57 3.63 3.70 3.21
Fixed Asset Turnover
21.85 26.12 30.32 21.73 18.26 25.83 32.23 36.45 37.60 27.44
Accounts Payable Turnover
10.04 11.86 11.29 6.40 9.27 22.94 15.31 12.27 13.69 13.75
Days Sales Outstanding (DSO)
34.89 39.18 47.10 60.96 48.83 39.09 41.54 37.65 38.59 45.07
Days Inventory Outstanding (DIO)
79.40 65.34 41.14 61.11 69.71 61.51 79.80 100.47 98.78 113.83
Days Payable Outstanding (DPO)
36.35 30.77 32.34 57.00 39.37 15.91 23.84 29.74 26.66 26.55
Cash Conversion Cycle (CCC)
77.93 73.74 55.90 65.07 79.17 84.69 97.49 108.37 110.71 132.35
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
162 135 135 132 137 147 364 438 499 484
Invested Capital Turnover
2.52 3.09 3.78 3.31 3.16 3.82 2.66 2.16 2.22 1.69
Increase / (Decrease) in Invested Capital
1.58 -27 0.33 -3.53 4.91 9.97 218 74 61 -15
Enterprise Value (EV)
326 298 290 498 426 1,705 4,894 4,236 2,657 2,015
Market Capitalization
400 376 300 518 444 1,838 5,099 4,478 2,878 2,312
Book Value per Share
$4.64 $4.37 $2.88 $2.86 $2.78 $4.54 $8.92 $10.38 $10.92 $11.78
Tangible Book Value per Share
$2.22 $1.98 $0.57 $0.67 $0.68 $2.66 $7.09 $8.61 $9.15 $10.02
Total Capital
236 213 175 182 184 280 568 680 719 781
Total Debt
0.00 0.00 30 30 30 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-74 -78 -9.78 -20 -17 -134 -204 -242 -220 -297
Capital Expenditures (CapEx)
7.28 9.84 8.03 10 13 7.82 10 14 18 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
42 20 24 11 11 32 77 140 190 157
Debt-free Net Working Capital (DFNWC)
116 98 64 61 58 166 281 382 410 454
Net Working Capital (NWC)
116 98 34 31 28 166 281 382 410 454
Net Nonoperating Expense (NNE)
7.78 7.72 26 6.34 6.91 2.50 4.21 -1.09 -7.74 -0.38
Net Nonoperating Obligations (NNO)
-74 -78 -9.78 -20 -17 -134 -204 -242 -220 -297
Total Depreciation and Amortization (D&A)
30 15 11 9.19 10 14 15 13 12 14
Debt-free, Cash-free Net Working Capital to Revenue
10.30% 4.32% 4.77% 2.45% 2.56% 5.92% 11.30% 16.16% 18.27% 18.82%
Debt-free Net Working Capital to Revenue
28.36% 21.34% 12.56% 13.84% 13.75% 30.64% 41.38% 44.01% 39.47% 54.55%
Net Working Capital to Revenue
28.36% 21.34% 6.69% 7.04% 6.68% 30.64% 41.38% 44.01% 39.47% 54.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.51) ($0.56) ($1.66) ($0.37) ($0.32) $0.57 $3.77 $0.63 $0.44 ($0.45)
Adjusted Weighted Average Basic Shares Outstanding
48.45M 49.59M 51.71M 54.04M 56.56M 59.07M 63.28M 65.06M 65.98M 65.88M
Adjusted Diluted Earnings per Share
($0.51) ($0.56) ($1.66) ($0.37) ($0.32) $0.54 $3.51 $0.60 $0.42 ($0.45)
Adjusted Weighted Average Diluted Shares Outstanding
48.45M 49.59M 51.71M 54.04M 56.56M 62.00M 67.86M 68.91M 69.32M 65.88M
Adjusted Basic & Diluted Earnings per Share
($0.51) ($0.56) ($1.66) ($0.37) ($0.32) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
51.49M 48.73M 50.16M 52.61M 54.99M 62.45M 64.44M 66.14M 65.41M 66.69M
Normalized Net Operating Profit after Tax (NOPAT)
-19 -23 -54 -14 -11 42 51 40 22 -30
Normalized NOPAT Margin
-4.55% -4.98% -10.60% -3.10% -2.54% 7.78% 7.54% 4.60% 2.08% -3.62%
Pre Tax Income Margin
-6.33% -5.90% -16.03% -4.25% -3.90% 6.33% 10.69% 6.23% 3.34% -3.81%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-103.21% -46.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 294.62% -35.95%

Quarterly Metrics and Ratios for Calix

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
37.22% 38.59% 35.18% 29.19% 11.64% 8.27% -9.48% -24.09% -23.84% -22.14%
EBITDA Growth
6.44% -9.13% -7.34% 13.83% -17.66% -155.32% -89.88% -152.29% -140.47% -78.18%
EBIT Growth
13.37% -5.80% -0.85% 26.99% -22.07% -193.29% -122.18% -197.23% -171.51% -56.93%
NOPAT Growth
-92.82% -47.59% 2.61% 3.11% 13.27% -176.60% -105.35% -202.17% -151.24% -55.07%
Net Income Growth
-92.42% -40.01% 18.22% 24.62% 26.11% -155.33% -98.93% -184.90% -123.41% -171.62%
EPS Growth
-92.72% -37.93% 16.67% 18.18% 26.32% -150.00% -100.00% -192.31% -125.00% -200.00%
Operating Cash Flow Growth
-37.94% -51.62% 10.14% 149.52% 134.60% 144.46% 81.10% 27.96% 1.57% 2.94%
Free Cash Flow Firm Growth
-154.48% 68.08% 64.17% 63.88% -37.65% -10.43% 41.87% 69.97% 102.91% 102.40%
Invested Capital Growth
19.06% 20.26% 21.68% 21.77% 21.26% 13.88% 9.21% 3.22% -1.95% -2.97%
Revenue Q/Q Growth
16.97% 3.46% 2.25% 4.40% 1.08% 0.34% -14.51% -12.45% 1.42% 2.58%
EBITDA Q/Q Growth
71.04% -29.27% -19.68% 17.15% 23.72% -147.52% 114.70% -705.18% 4.24% -109.21%
EBIT Q/Q Growth
110.74% -34.32% -25.15% 22.57% 29.32% -178.62% 82.20% -437.24% 4.88% -72.53%
NOPAT Q/Q Growth
74.14% -15.91% -24.35% -6.92% 91.31% -156.86% 94.72% -1,677.49% 4.05% -72.08%
Net Income Q/Q Growth
78.74% -11.28% -19.53% -2.34% 80.87% -138.93% 101.56% -7,826.21% 50.14% -351.71%
EPS Q/Q Growth
72.73% -5.26% -22.22% -7.14% 84.62% -137.50% 100.00% 0.00% 50.00% -350.00%
Operating Cash Flow Q/Q Growth
-4.07% -9.07% 32.87% 115.29% -9.81% -5.25% -1.56% 52.11% -28.41% -3.98%
Free Cash Flow Firm Q/Q Growth
75.35% -18.36% -17.61% -5.24% 6.04% 5.05% 38.09% 45.62% 109.10% -21.67%
Invested Capital Q/Q Growth
5.30% 6.01% 5.24% 3.66% 4.86% -0.44% 0.92% -2.03% -0.39% -1.48%
Profitability Metrics
- - - - - - - - - -
Gross Margin
50.17% 51.08% 51.22% 52.28% 53.27% 42.78% 54.16% 54.31% 54.76% 55.00%
EBITDA Margin
9.52% 6.51% 5.11% 5.74% 7.02% -3.33% 0.57% -3.95% -3.73% -7.61%
Operating Margin
8.46% 5.34% 3.97% 4.53% 6.04% -4.57% -0.90% -5.73% -5.42% -9.10%
EBIT Margin
8.41% 5.34% 3.91% 4.59% 5.87% -4.60% -0.96% -5.88% -5.51% -9.27%
Profit (Net Income) Margin
5.69% 4.88% 3.84% 3.59% 6.43% -2.49% 0.05% -4.02% -1.97% -8.70%
Tax Burden Percent
65.68% 84.67% 84.13% 65.87% 93.44% 73.13% 22.01% 91.66% 50.92% 114.60%
Interest Burden Percent
102.99% 107.94% 116.79% 118.83% 117.17% 74.12% -21.60% 74.57% 70.36% 81.86%
Effective Tax Rate
34.32% 15.33% 15.87% 34.13% 6.56% 0.00% 77.99% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
11.70% 9.78% 7.43% 6.80% 12.59% -7.10% -0.42% -7.88% -6.81% -10.78%
ROIC Less NNEP Spread (ROIC-NNEP)
11.56% 9.39% 6.90% 6.15% 11.73% -7.91% -0.64% -7.87% -8.17% -8.92%
Return on Net Nonoperating Assets (RNNOA)
-4.14% -3.36% -2.48% -2.21% -4.07% 2.61% 0.22% 2.77% 2.87% 3.08%
Return on Equity (ROE)
7.57% 6.43% 4.95% 4.59% 8.52% -4.49% -0.20% -5.11% -3.94% -7.70%
Cash Return on Invested Capital (CROIC)
-4.41% -8.44% -9.97% -10.35% -10.04% -8.37% -6.45% -8.60% -3.17% -3.12%
Operating Return on Assets (OROA)
8.61% 5.69% 4.31% 5.25% 6.67% -5.23% -1.06% -6.02% -5.26% -8.19%
Return on Assets (ROA)
5.82% 5.20% 4.24% 4.11% 7.30% -2.84% 0.05% -4.12% -1.89% -7.69%
Return on Common Equity (ROCE)
7.57% 6.43% 4.95% 4.59% 8.52% -4.49% -0.20% -5.11% -3.94% -7.70%
Return on Equity Simple (ROE_SIMPLE)
7.56% 0.00% 5.92% 5.98% 6.37% 0.00% 2.67% 0.33% -2.37% 0.00%
Net Operating Profit after Tax (NOPAT)
13 11 8.36 7.78 15 -8.46 -0.45 -7.95 -7.63 -13
NOPAT Margin
5.56% 4.52% 3.34% 2.98% 5.64% -3.20% -0.20% -4.01% -3.80% -6.37%
Net Nonoperating Expense Percent (NNEP)
0.14% 0.39% 0.53% 0.65% 0.85% 0.81% 0.22% 0.00% 1.36% -1.85%
Return On Investment Capital (ROIC_SIMPLE)
- 1.63% - - - -1.18% - - - -1.68%
Cost of Revenue to Revenue
49.83% 48.92% 48.78% 47.72% 46.73% 57.22% 45.84% 45.69% 45.24% 45.00%
SG&A Expenses to Revenue
8.14% 9.04% 9.23% 9.47% 9.59% 10.31% 11.62% 11.41% 11.53% 13.01%
R&D to Revenue
14.05% 15.77% 17.27% 17.37% 17.80% 15.98% 19.63% 22.27% 22.63% 22.25%
Operating Expenses to Revenue
41.71% 45.74% 47.24% 47.76% 47.23% 47.34% 55.06% 60.04% 60.19% 64.10%
Earnings before Interest and Taxes (EBIT)
20 13 9.77 12 15 -12 -2.17 -12 -11 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
23 16 13 15 19 -8.81 1.29 -7.83 -7.50 -16
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
6.16 6.59 4.94 4.46 4.05 4.00 2.94 3.08 3.25 2.96
Price to Tangible Book Value (P/TBV)
7.50 7.95 5.89 5.29 4.79 4.77 3.49 3.64 3.82 3.48
Price to Revenue (P/Rev)
4.99 5.16 3.80 3.33 2.98 2.77 2.15 2.44 2.84 2.78
Price to Earnings (P/E)
81.46 109.20 83.42 74.56 63.53 98.13 110.14 928.99 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.23% 0.92% 1.20% 1.34% 1.57% 1.02% 0.91% 0.11% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
9.09 9.68 7.13 6.37 5.57 5.33 3.86 4.18 4.57 4.17
Enterprise Value to Revenue (EV/Rev)
4.69 4.88 3.52 3.07 2.74 2.56 1.91 2.16 2.52 2.42
Enterprise Value to EBITDA (EV/EBITDA)
55.09 64.97 50.63 45.87 44.53 70.89 74.81 646.48 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
69.30 81.42 62.39 55.51 55.00 106.07 148.26 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
76.05 106.11 81.68 75.35 66.51 123.10 171.52 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
111.41 155.85 117.70 79.23 58.82 47.24 30.95 30.43 33.01 29.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.36 -0.36 -0.36 -0.36 -0.35 -0.33 -0.34 -0.35 -0.35 -0.35
Leverage Ratio
1.32 1.30 1.29 1.28 1.28 1.31 1.26 1.24 1.22 1.25
Compound Leverage Factor
1.36 1.41 1.51 1.52 1.50 0.97 -0.27 0.93 0.86 1.03
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
11.76 14.02 11.81 11.02 11.58 8.80 8.39 9.52 10.50 9.58
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.96 3.31 3.58 3.69 4.22 3.19 3.96 4.28 4.50 4.46
Quick Ratio
1.86 2.03 2.17 2.22 2.38 1.85 2.33 2.58 2.87 2.87
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-53 -63 -74 -78 -73 -69 -43 -23 2.12 1.66
Operating Cash Flow to CapEx
197.82% 127.00% 175.66% 318.16% 417.13% 375.73% 396.09% 375.45% 493.19% 298.37%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.02 1.07 1.10 1.14 1.14 1.14 1.11 1.02 0.96 0.88
Accounts Receivable Turnover
8.31 9.70 10.36 10.83 11.25 9.46 10.55 10.65 10.73 8.10
Inventory Turnover
3.68 3.63 3.53 3.84 3.36 3.70 3.64 3.52 3.48 3.21
Fixed Asset Turnover
35.30 36.45 37.52 39.00 38.13 37.60 36.09 31.82 29.56 27.44
Accounts Payable Turnover
8.16 12.27 12.65 16.60 11.08 13.69 18.49 19.94 18.80 13.75
Days Sales Outstanding (DSO)
43.92 37.65 35.24 33.69 32.44 38.59 34.58 34.29 34.02 45.07
Days Inventory Outstanding (DIO)
99.18 100.47 103.49 94.94 108.57 98.78 100.24 103.84 104.76 113.83
Days Payable Outstanding (DPO)
44.75 29.74 28.86 21.99 32.96 26.66 19.74 18.31 19.41 26.55
Cash Conversion Cycle (CCC)
98.35 108.37 109.88 106.64 108.05 110.71 115.08 119.82 119.36 132.35
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
413 438 461 478 501 499 503 493 491 484
Invested Capital Turnover
2.10 2.16 2.22 2.28 2.23 2.22 2.11 1.96 1.79 1.69
Increase / (Decrease) in Invested Capital
66 74 82 85 88 61 42 15 -9.75 -15
Enterprise Value (EV)
3,754 4,236 3,287 3,042 2,790 2,657 1,945 2,060 2,243 2,015
Market Capitalization
3,989 4,478 3,544 3,306 3,040 2,878 2,184 2,322 2,531 2,312
Book Value per Share
$9.93 $10.38 $10.85 $11.20 $11.32 $10.92 $11.37 $11.51 $11.83 $11.78
Tangible Book Value per Share
$8.15 $8.61 $9.10 $9.44 $9.57 $9.15 $9.59 $9.74 $10.07 $10.02
Total Capital
648 680 718 742 751 719 743 754 779 781
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-235 -242 -257 -264 -250 -220 -239 -261 -288 -297
Capital Expenditures (CapEx)
3.39 4.81 4.62 5.49 3.78 3.97 3.71 5.95 3.24 5.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
120 140 158 173 198 190 193 176 168 157
Debt-free Net Working Capital (DFNWC)
355 382 415 437 448 410 433 437 455 454
Net Working Capital (NWC)
355 382 415 437 448 410 433 437 455 454
Net Nonoperating Expense (NNE)
-0.30 -0.88 -1.24 -1.59 -2.07 -1.86 -0.55 0.01 -3.66 4.80
Net Nonoperating Obligations (NNO)
-235 -242 -257 -264 -250 -220 -239 -261 -288 -297
Total Depreciation and Amortization (D&A)
2.63 2.87 3.02 3.00 3.04 3.37 3.46 3.81 3.58 3.42
Debt-free, Cash-free Net Working Capital to Revenue
15.00% 16.16% 16.97% 17.41% 19.46% 18.27% 19.02% 18.45% 18.82% 18.82%
Debt-free Net Working Capital to Revenue
44.35% 44.01% 44.52% 44.04% 44.00% 39.47% 42.59% 45.86% 51.13% 54.55%
Net Working Capital to Revenue
44.35% 44.01% 44.52% 44.04% 44.00% 39.47% 42.59% 45.86% 51.13% 54.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.21 $0.17 $0.15 $0.14 $0.26 ($0.11) $0.00 ($0.12) ($0.06) ($0.27)
Adjusted Weighted Average Basic Shares Outstanding
65.36M 65.06M 66.04M 66.27M 66.29M 65.98M 65.34M 65.68M 66.08M 65.88M
Adjusted Diluted Earnings per Share
$0.19 $0.18 $0.14 $0.13 $0.24 ($0.09) $0.00 ($0.12) ($0.06) ($0.27)
Adjusted Weighted Average Diluted Shares Outstanding
69.17M 68.91M 69.71M 69.66M 69.58M 69.32M 68.12M 65.68M 66.08M 65.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
65.44M 66.14M 66.24M 66.32M 65.87M 65.41M 65.53M 65.80M 66.32M 66.69M
Normalized Net Operating Profit after Tax (NOPAT)
13 11 8.36 7.78 15 -8.46 -1.42 -7.95 -7.63 -13
Normalized NOPAT Margin
5.56% 4.52% 3.34% 2.98% 5.64% -3.20% -0.63% -4.01% -3.80% -6.37%
Pre Tax Income Margin
8.66% 5.76% 4.56% 5.45% 6.88% -3.41% 0.21% -4.38% -3.88% -7.59%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 2.78% 22.55% 88.63% 294.62% 448.57% 3,206.68% -259.07% -35.95%

Frequently Asked Questions About Calix's Financials

When does Calix's financial year end?

According to the most recent income statement we have on file, Calix's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Calix's net income changed over the last 9 years?

Calix's net income appears to be on an upward trend, with a most recent value of -$29.75 million in 2024, rising from -$26.33 million in 2015. The previous period was $29.33 million in 2023.

What is Calix's operating income?
Calix's total operating income in 2024 was -$43.03 million, based on the following breakdown:
  • Total Gross Profit: $453.59 million
  • Total Operating Expenses: $496.63 million
How has Calix revenue changed over the last 9 years?

Over the last 9 years, Calix's total revenue changed from $407.46 million in 2015 to $831.52 million in 2024, a change of 104.1%.

How much debt does Calix have?

Calix's total liabilities were at $158.33 million at the end of 2024, a 29.0% decrease from 2023, and a 79.7% increase since 2015.

How much cash does Calix have?

In the past 9 years, Calix's cash and equivalents has ranged from $23.63 million in 2015 to $80.81 million in 2020, and is currently $43.16 million as of their latest financial filing in 2024.

How has Calix's book value per share changed over the last 9 years?

Over the last 9 years, Calix's book value per share changed from 4.64 in 2015 to 11.78 in 2024, a change of 153.8%.

Remove Ads


This page (NYSE:CALX) was last updated on 4/10/2025 by MarketBeat.com Staff
From Our Partners